Ratings
0
Nobody has rated this yet. Be the first!
Works
9
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Outcome after individualized stereoelectroencephalography (sEEG) implantation and navigated resection in patients with lesional and non-lesional focal epilepsy
Single-session image-guided robotic radiosurgery and quality of life for glomus jugulare tumors
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias
Interdisciplinary treatment of unruptured intracranial aneurysms: impact of intraprocedural rupture and ischemia in 563 aneurysms
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.
Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation
Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference
